Clinical trial · Interventional
Hysteroscopic Guided Endometrial Sampling: Prospective Comparison Between 5Fr and 7Fr Biopsy Forceps (HYSTEROBIO)
NCT04519554CI-TRIAL-00046882HYSTEROBIOunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Indication for hysteroscopic guided biopsy compared to blind biopsy have been little evaluated. However, this kind of biopsy is usually performed in many centre. They allow exploration of uterine cavity but also to perform guided biopsies on the most suspicious area. However, with 5Fr forceps, biopsy are often too small to conclude.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biopsy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endometrial sampling | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- 5FR + 7FR
- description
- Each woman is its own control and had biopsies with the 2 size of forceps. In this group first with 5FR then 7 FR
- interventionNames
- Device: Endometrial sampling
- type
- OTHER
- label
- 7FR + 5FR
- description
- Each woman is its own control and had biopsies with the 2 size of forceps. In this group first with 7FR then 5FR
- interventionNames
- Device: Endometrial sampling
Primary outcomes (1)
- measure
- To evaluate ability to give a pathologic conclusion after 5Fr and 7Fr forceps biopsies
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * • Woman over 18 year-old with abnormal uterine bleeding (or endometrium thickness over 10mm) and risk factors of endometrial carcinoma, or endometrium thickness over 5mm in a menopausal woman or abnormal uterine bleeding after 45 years old. * Woman who speak and understand french * Woman who give her written informed consent * Woman covered by french medical insurance Exclusion Criteria: * • Pregnant or breastfeeding patient * Patient under guardianship, curators or safeguard of justice. * Patient participating in another ongoing study.
References
Publications (0)
Data not yet available
No reference posted for this study.